Action of KI, thyroxine and cyclic AMP on [3H]uridine incorporation into the RNA of thyroid slices.
Potassium iodide (KI) has been shown to impair thyroid protein biosynthesis both in vivo and in vitro. The present study was performed in order to clarify its mechanism of action. Ribonucleic acid (RNA) synthesis was studied in beef thyroid slices with either [32P] or [3H]-uridine as labelled precursors. Both KI and thyroxine (T4) at 10(-5) M significantly decreased RNA labelling under our conditions. In other experiments RNA degradation was examined in pulse-labelled and actinomycin D-treated slices. KI did not modify the degradation of the [3H]-RNA thus indicating that it interferes with the biosynthesis rather than with the degradation of RNA. Taking the perchloric acid soluble radioactivity as a rough index of the precursor pool the present results would indicate an action at this level. Both KC1O4 and methylmercapto-imidazole relieved the gland from the inhibitory action of KI, supporting the view that an intracellular and organified form of iodine is responsible for this action. Since T4 also reproduced the effects of KI on RNA synthesis we would like to propose iodothyronines as the intermediates of this action. Cyclic AMP has been shown to stimulate thyroid protein biosynthesis. The present results demonstrate an action at the RNA level. Cyclic AMP increased both the PCA-soluble and RNA-linked radioactivity, thus suggesting an effect at the RNA precursor pool. KI at 10(-5) M blocked the action of 2 mM cyclic AMP.
D000818:Animals; D002417:Cattle; D000242:Cyclic AMP / Q000494:pharmacology*; D007553:Isotope Labeling; D011193:Potassium Iodide / Q000494:pharmacology*; D012313:RNA / Q000096:biosynthesis / Q000378:metabolism*; D013961:Thyroid Gland / Q000378:metabolism*; D013974:Thyroxine / Q000494:pharmacology*; D014529:Uridine / Q000378:metabolism*
D011193:Potassium Iodide; D012313:RNA; D000242:Cyclic AMP; D013974:Thyroxine; D014529:Uridine